FOXM1 and breast carcinoma: Of interest, we also find that FOXM1 inhibition can synergize with activators of ferroptosis to markedly enhance anticancer activities in ER-positive and triple-negative cells, suggesting that this synergy may be broadly applicable to different subtypes of breast cancer.